Top Story

30-year-old woman with semaglutide use. Patient had stopped semaglutide use 36 days prior to post-semaglutide scan. Patient's weight was 148 kg on pre-semaglutide scan and 176 kg on post-semaglutide scan. Patient was thus assigned to weight-gain group. (A) Coronal maximum-intensity projection (MIP) image from pre-semaglutide scan shows organ segmentations. (B) Axial image from pre-semaglutide scan at L3 level shows color-coded tissue segmentations. (C) Coronal MIP image from post-semaglutide scan shows organ segmentations. (D) Axial image from post-semaglutide scan at L3 level shows color-coded tissue segmentations. Segmented visceral adipose tissue (VAT) is colored yellow, subcutaneous adipose tissue (SAT) is colored blue, skeletal muscle is colored red, liver is colored red, and spleen (not evaluated in present investigation) is colored orange. On pre- and post-semaglutide scans, VAT area was 358.5 cm2 and 412.1 cm2, muscle area was 186.8 cm2 and 225.2 cm2, muscle attenuation was -5.2 HU and -11.0 HU, liver volume was 2,579 and 3,851 mL, and liver attenuation was 77.8 HU and 59.2 HU, respectively. Images and caption courtesy of the American Journal of Roentgenology.
Medical Imaging
Biomarker, tissue study shows body composition in patients treated with Ozempic
Artificial intelligence tools may aid healthcare teams in monitoring the negative impacts of weight loss and diabetes drugs.
Featured
Proscia Embeddings
Artificial Intelligence
Proscia launches pathology AI model toolkit
Crispr Cas9 Gene Editing
Emerging Technology
CRISPR patent decisions could trigger waves globally
Latest News
Doctor Patient Consult
Ibex survey indicates some comfort with AI in cancer diagnostics
September 25, 2024
Olfactory Bulb Brain Cr Social
Pathologists detect microplastics in human brain tissue
September 25, 2024
Body composition in patients treated with Ozempic
Sponsored
Body composition in patients treated with Ozempic
September 20, 2024
Colorized transmission electron micrograph of avian influenza A H5N1 virus particles shown in yellow.
CDC adds commercial lab contracts for infectious disease, bird flu testing
September 17, 2024
Fda Button Social
FDA Clearance
Abionic sepsis test gets FDA 510(k) clearance
Agreement
Codexis, Alphazyme forge licensing agreement for genomics enzymes
Artificial Intelligence
Proscia launches pathology AI model toolkit
Emerging Technology
CRISPR patent decisions could trigger waves globally
Money Hundred Bills Social
Financing
Mendaera raises $73M for handheld robotic platform
Research Alliance
Owlstone, FDA's OSEL partner to develop VOC ID methods
Emerging Technology
CRISPR patent decisions could trigger waves globally
PCR
Roche launches diagnostic test for 12 respiratory viruses
Colorectal Cancer Social (1)
Emerging Technology
Geneoscopy adds N.Y. state lab permit for wider ColoSense testing
PCR
Roche launches diagnostic test for 12 respiratory viruses
Research Alliance
Cepheid partners with Fleming Initiative on antimicrobial resistance
Pathology and AI
Ibex survey indicates some comfort with AI in cancer diagnostics
More from LabPulse.com
Abionic sepsis test gets FDA 510(k) clearance
By LabPulse.com staff writers
Abionic, a diagnostics firm specializing in rapid early detection, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its IVD Capsule PSP test for sepsis.
October 3, 2024
Fda Button Social
Codexis, Alphazyme forge licensing agreement for genomics enzymes
By LabPulse.com staff writers
Enzyme engineering firm Codexis has entered into a commercial and manufacturing license agreement with Alphazyme for multiple enzymes from Codexis' life science enzyme portfolio.
October 3, 2024
Hands Shaking Deal Social
Mendaera raises $73M for handheld robotic platform
By LabPulse.com staff writers
Healthcare tech firm Mendaera announced that it has raised $73 million in series B financing.
October 2, 2024
Money Hundred Bills Social
Owlstone, FDA's OSEL partner to develop VOC ID methods
By LabPulse.com staff writers
Owlstone Medical entered a research collaboration agreement with the FDA's Center for Devices and Radiological Health Office of Science and Engineering Laboratories (OSEL) to develop methods of identifying volatile organic compounds (VOCs) in breath.
September 30, 2024
Molecule Social
Lagging claims payment disputes with providers to cost Anthem $8.5M
By LabPulse.com staff writers
The California Department of Managed Health Care has fined Anthem Blue Cross $8.5 million for failing to address claims payment disputes in a timely manner from doctors, hospitals, and other healthcare providers.
October 1, 2024
Claim Denied Form
Qiagen launches clinical oncology testing system
By LabPulse.com staff writers
Qiagen has expanded its digital polymerase chain reaction portfolio and plans to enter the clinical testing space in North America and the European Union.
October 1, 2024
Test Tubes Social (2)
Geneoscopy adds N.Y. state lab permit for wider ColoSense testing
By LabPulse.com staff writers
Noninvasive colorectal cancer screening test developer Geneoscopy has received a laboratory permit from the New York State Department of Health.
October 1, 2024
Colorectal Cancer Social (1)
Roche launches diagnostic test for 12 respiratory viruses
By LabPulse.com staff writers
Roche Diagnostics has launched its first test using its new high-throughput technology that enables users of Roche's Cobas analyzers to simultaneously test for 12 respiratory viruses.
September 26, 2024
Roche Aacc 2019 Social
Lab manager, employees, sales reps on hook in $7.2M whistleblower fraud case
By LabPulse.com staff writers
Settlements reveal the consequences of clinical laboratory tests used for nonmedical purposes.
September 27, 2024
Gavel Money Social
Cepheid partners with Fleming Initiative on antimicrobial resistance
By LabPulse.com staff writers
Diagnostics firm Cepheid has entered a partnership with the Fleming Initiative, a global collaboration established by the Imperial College Healthcare National Health Service Trust and Imperial College London to combat antimicrobial resistance.
September 26, 2024
Colorized scanning electron micrograph of methicillin-resistant Staphylococcus aureus (MRSA) bacteria (gold) interacting with a human neutrophil (red). Image captured at NIAID's Rocky Mountain Laboratories (RML) in Hamilton, Montana.
Angle, NuProbe sign licensing agreement on NGS panel
By LabPulse.com staff writers
Liquid biopsy firm Angle has signed a licensing agreement with NuProbe to use NuProbe's next-generation sequencing (NGS) panel in its pan-cancer molecular sequencing assay.
September 23, 2024
Lab Pcr Tubes Dna Social
CDC lab division restructure bolsters quality, technical roles
By LabPulse.com staff writers
The U.S. Centers for Disease Control and Prevention's (CDC) Office of Laboratory Science and Safety has been retitled, plus other updates were announced.
September 23, 2024
Cdc Logo